Joel Frank

Person

Sandy, UT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Oral allopregnanolone compositions and methods of use
- Patent number 11,969,434
- Issue date Apr 30, 2024
- Jonathan Ogle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters
- Patent number 11,872,235
- Issue date Jan 16, 2024
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(17-ß)-3-oxoandrost-4-en-17YL tridecanoate compositions and methods...
- Patent number 11,707,467
- Issue date Jul 25, 2023
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods...
- Patent number 11,370,811
- Issue date Jun 28, 2022
- Kilyoung Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
- Patent number 11,298,365
- Issue date Apr 12, 2022
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
- Patent number 9,757,389
- Issue date Sep 12, 2017
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
- Patent number 9,498,485
- Issue date Nov 22, 2016
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Oral Allopregnanolone Compositions and Methods of Use
- Publication number 20240252513
- Publication date Aug 1, 2024
- Lipocine Inc.
- Jonathan Ogle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oral Allopregnanolone Compositions and Methods of Use
- Publication number 20240173335
- Publication date May 30, 2024
- Lipocine Inc.
- Jonathan Ogle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(17-)-3-Oxoandrost-4-EN-17-YL Dodecanoate Compositions and Methods...
- Publication number 20220332753
- Publication date Oct 20, 2022
- Lipocine Inc.
- Kilyoung Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
- Publication number 20210069211
- Publication date Mar 11, 2021
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION AND METHODS
- Publication number 20200155575
- Publication date May 21, 2020
- Lipocine Inc.
- Mahesh Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
- Publication number 20200046731
- Publication date Feb 13, 2020
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods...
- Publication number 20190388434
- Publication date Dec 26, 2019
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(17-ß)-3-OXOANDROST-4-EN-17YL TRIDECANOATE COMPOSITIONS AND METHODS...
- Publication number 20190350943
- Publication date Nov 21, 2019
- Lipocine Inc.
- Mahesh V. Patel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITION AND METHODS
- Publication number 20190269700
- Publication date Sep 5, 2019
- Lipocine Inc.
- Mahesh Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
- Publication number 20180125858
- Publication date May 10, 2018
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods...
- Publication number 20180104257
- Publication date Apr 19, 2018
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION AND METHODS
- Publication number 20180078568
- Publication date Mar 22, 2018
- Lipocine Inc.
- Mahesh Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHOD...
- Publication number 20170246187
- Publication date Aug 31, 2017
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
- Publication number 20170056415
- Publication date Mar 2, 2017
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS...
- Publication number 20160193225
- Publication date Jul 7, 2016
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOAVAILABLE SOLID STATE (17-SS;)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
- Publication number 20160184320
- Publication date Jun 30, 2016
- Lipocine Inc.
- Mahesh V. Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION AND METHODS
- Publication number 20160184324
- Publication date Jun 30, 2016
- Lipocine Inc.
- Mahesh Patel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Oral allopregnanolone compositions and methods of use

Bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters

(17-ß)-3-oxoandrost-4-en-17YL tridecanoate compositions and methods...

(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods...

Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters

Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters

Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters

Patents Applicationslast 30 patents

Oral Allopregnanolone Compositions and Methods of Use

Oral Allopregnanolone Compositions and Methods of Use

(17-)-3-Oxoandrost-4-EN-17-YL Dodecanoate Compositions and Methods...

BIOAVAILABLE SOLID STATE (17- &#946;)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS

PHARMACEUTICAL COMPOSITION AND METHODS

BIOAVAILABLE SOLID STATE (17- &#946;)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS

(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods...

(17-ß)-3-OXOANDROST-4-EN-17YL TRIDECANOATE COMPOSITIONS AND METHODS...

PHARMACEUTICAL COMPOSITION AND METHODS

BIOAVAILABLE SOLID STATE (17- &#946;)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS

(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods...

PHARMACEUTICAL COMPOSITION AND METHODS

(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHOD...

BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS

(17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS...

BIOAVAILABLE SOLID STATE (17-SS;)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS

PHARMACEUTICAL COMPOSITION AND METHODS

BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS

BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS

BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS